Question
Q6 3 marks Short Notes ★ ✓
Answer
Examples: Alendronate, Risedronate, Zoledronic acid, Pamidronate
Mechanism of action
Bind to hydroxyapatite at sites of active bone resorption; taken up by osteoclasts, inhibit farnesyl pyrophosphate synthase, disrupting osteoclast function and promoting apoptosis — reducing bone resorption
Uses
Osteoporosis, Paget’s disease, hypercalcaemia of malignancy, bone metastases
Adverse effects
Oesophagitis (oral)
Osteonecrosis of the jaw
Atypical femoral fractures (long-term)
Acute phase reaction (IV)
Hypocalcaemia
1 Drugs for Disorders of Calcium Balance
Other Years Asked
1 Classify bisphosphonates. Explain in detail on the mechanism of action, uses and adverse effects of bisphosphonates 2024 March (Supplementary) (2019 Scheme) Short Essay · 8 marks 2 A 60-year-old lady presents with back pain and in the legs. She also complains of a recent fracture in the right wrist joint. After investigation, the physician made a diagnosis of Osteoporosis. She was prescribed Alendronate. Explain the mechanism of action and adverse effects of Alendronate. (4+2) 2025 March (Supplementary (SAY)) (2019 Scheme) Short Essay · 6 marks 3 A 30 years old pregnant woman attended to hospital with a complaint of sudden onset of swelling of right leg and tenderness over calf. Venous Doppler of right leg suggestive of presence of a large thrombus in leg veins. (a) Classify anticoagulants (b) Choose the ideal drug for this patient, write its mechanism of action and adverse (c) What are advantages of low molecular weight heparins 2021 December (Supplementary) (2010 Scheme) Essay · 6 marks 4 Bisphosphonates 2015 February (2010 Scheme) Short Note · 3 marks 5 Bisphosphonates 2014 September (Supplementary) (2010 Scheme) Short Note · 3 marks 6 Mention two important uses and adverse effects of glucocorticoids. 2017 February (2010 Scheme) Short Answer · 1 mark 7 Treatment of Paget’s disease 2016 February (2010 Scheme) Short Answer · 1 mark 8 List two advantages of low molecular weight heparin over standard heparin 2013 September (Supplementary) (2010 Scheme) Short Answer · 1 mark 9 Bisphosphonates 2014 March (2010 Scheme) Short Answer · 1 mark 10 Treatment of osteoporosis 2017 February (2010 Scheme) Short Answer · 1 mark 11 Osteoporosis. 2013 September (Supplementary) (2010 Scheme) Short Answer · 1 mark 12 Alendronate in osteoporosis management 2022 October (Supplementary) (2010 Scheme) Short Answer · 1 mark 13 Bisphosphonates. 2025 March (Supplementary) (2010 Scheme) Short Answer · 0.3 marks 14 Bisphosphonates 2025 August (Supplementary) (2010 Scheme) Short Answer · 0.3 marks 15 Bisphosphonates 2021 February (Supplementary) (2010 Scheme) Short Answer · 0.3 marks 16 Bisphosphonates used in postmenopausal Osteoporosis. 2022 May (Supplementary) (2010 Scheme) Short Answer · 0.3 marks 17 Drugs used for osteoporosis 2024 June (Supplementary) (2019 Scheme) Short Answer · 0.2 marks 18 Vitamin D preparations 2024 June (Supplementary) (2019 Scheme) Short Answer · 0.2 marks 19 Drugs for treating Osteoporosis. 2023 January (Supplementary) (2019 Scheme) Short Answer · 0.2 marks